Get the Stockscreener App
4.29
4.45%
-0.20
Cryo Cell International Inc stock is traded at $4.29, with a volume of 286.
It is down -4.45% in the last 24 hours and up +7.52% over the past month.
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
See More
Previous Close:
$4.49
Open:
$4.29
24h Volume:
286
Relative Volume:
0.02
Market Cap:
$34.59M
Revenue:
$31.28M
Net Income/Loss:
$-2.67M
P/E Ratio:
-12.94
EPS:
-0.3315
Net Cash Flow:
$4.94M
1W Performance:
-2.94%
1M Performance:
+7.52%
6M Performance:
+9.73%
1Y Performance:
-3.38%
1-Day Range:
$4.29
$4.29
1-Week Range:
$4.2785
$4.85
52-Week Range:
$2.72
$4.90
Cryo Cell International Inc Stock (CCEL) Company Profile
Name
Cryo Cell International Inc
Sector
Industry
Phone
813 749 2100
Address
700 Brooker Creek Boulevard, Suite 1800, Oldsmar
Compare CCEL vs HCA, THC, EHC, DVA, FMS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CCEL
Cryo Cell International Inc
|
4.29 | 34.59M | 31.28M | -2.67M | 4.94M | -0.3315 |
HCA
Hca Healthcare Inc
|
470.25 | 101.81B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
270.12 | 21.75B | 21.46B | 2.65B | 3.35B | 19.23 |
EHC
Encompass Health Corp
|
124.02 | 12.23B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
187.32 | 11.95B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
22.41 | 11.93B | 22.44B | 1.35B | 2.03B | 1.9002 |
Cryo Cell International Inc Stock (CCEL) Latest News
Cryo-Cell International(CCEL) Stock Options Chain | Quotes & News - Moomoo
Four director nominees face a shareholder vote at Cryo-Cell (CCEL) on October 27, 2026. - Stock Titan
Cryo-Cell International, Inc. (CCEL) Tops Q3 EPS by 13c - StreetInsider
Cryo-Cell International earnings beat by $0.13, revenue topped estimates - Investing.com
Cryo-Cell International earnings beat by $0.13, revenue topped estimates - Investing.com UK
Goodyear Tire, Cryo-Cell International And 3 Stocks To Watch Heading Into Monday - Benzinga
Cryo-Cell Q3FY26 Results: Net income rises 70% to $1.27 million - scanx.trade
CRYO-CELL International (CCEL) Q3 Earnings Beat Expectations, Sh - GuruFocus
Cryo-Cell International Posts $7.82 Million Q3 Revenue, $0.16 GAAP EPS - tokenpost.com
CRYO CELL INTERNATIONAL 3Q FY2026: Revenue $7.82M, 10-Q Summary - TradingView
Cryo-Cell International Q3 net income, EPS rise - TradingView
Q3 profit rose from $749K at Cryo-Cell (CCEL) as revenue stayed near $7.82M. - Stock Titan
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2026 Financial Results - Business Wire
Cryo-Cell International Q3 Net Income USD 1.2 - Moomoo
Cryo-Cell International Q3 2026 Earnings Results and Report - MarketBeat
CRYO CELL INTERNATIONAL Announces 2026 Annual Stockholder Meeting Date (AMEX: CCEL) - Kalkine Media
Cryo-Cell Sets Record Date for 2026 Shareholder Meeting - The Globe and Mail
2026 meeting date set for Cryo-Cell (CCEL) investors - Stock Titan
Cryo Cell International sets Oct. 27, 2026 annual meeting; record date Sept. 21, 2026 - tradingview.com
Stem Cell/Cord Blood Banking Market Research Reveals Path To $24.47 Billion By 2030 - openPR.com
Stem Cell Umbilical Cord Blood Market Size Report, 2033 - Grand View Research
Cryo-Cell (CCEL) Earnings Snapshot: The EPS Result Is Above Expectation for the Current Session; Post-Earnings: The Stock Ends Up 3.56% in Latest TradingFree Cash Flow Trends - vinanet.vn
Cryo-Cell (CCEL) Earnings Snapshot: The EPS Result Is Above Expectation for the Current Session; Post-Earnings: The Stock Ends Up 3.56% in Latest TradingEBITDA Margin Trends - dars.gov.et
JEXYY Stock Price and Chart — OTC:JEXYY - TradingView
CCEL Q2 2026 Earnings: EPS of $0.07 Exceeds Expectations, Stock Edges HigherSurprise Factor Analysis - Vinanet
Cell Processing Technologies Market Demonstrates Long-Term Growth Potential At 13.5% CAGR - openPR.com
Why CoreWeave Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - Sahm
CCEL Q2 2026 Earnings: EPS Exceeds Estimates as Shares Rally 14.25%Earnings Season Outlook - vinanet.vn
CCEL Q2 2026 Earnings: Beats with EPS of $0.07, Shares Jump 10.5%Analyst Consensus Shift - vinanet.vn
Cryo-Cell International (CCEL) Holds Flat at $3.51 Amid Tight Trading RangeRSI Overbought Alerts - careplusvn.com
Cryo-Cell International (CCEL) Holds Flat at $3.51 Amid Tight Trading RangeWyckoff Spring - dars.gov.et
Cryo-Cell International (CCEL) Slides 2.5% to $3.51 as Key Support at $3.33 LoomsOverbought Signal Alerts - vinanet.vn
Cryo-Cell International (CCEL) Slides 2.5% to $3.51 as Key Support at $3.33 LoomsOBV Breakout - careplusvn.com
Cryo-Cell International (CCEL) Slides 2.5% to $3.51 as Key Support at $3.33 LoomsFundamentals - dars.gov.et
Cryo-Cell International (CCEL) Slides 2.5% to $3.51 as Key Support at $3.33 LoomsVolume Profile - dars.gov.et
Cryo-Cell International (CCEL) Slides 2.5% to $3.51 as Key Support at $3.33 LoomsDealer Positioning - dars.gov.et
Cryo-Cell International (CCEL) Slides 2.5% to $3.51 as Key Support at $3.33 LoomsKey Reversal Day - dars.gov.et
SARO Stock Price and Chart — NYSE:SARO - TradingView
Cryo-Cell International (CCEL) moves 600,191 shares to new 2026 trust - Stock Titan
Cryo-Cell International Inc (CCEL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cryo-Cell International (CCEL) Gains 2.25% as Stock Holds Above Key SupportRetail Sentiment - vinanet.vn
Cryo-Cell International (CCEL) Advances 2.3%: Stem Cell Banking Stock Tests Key ResistanceRSI Oversold Picks - vinanet.vn
Cryo-Cell International, Inc. Revenue Breakdown – AMEX:CCEL - TradingView
CCEL Q2 2026 Earnings: Positive Earnings Surprise as EPS Turns ProfitableDownward Estimate Revision - dars.gov.et
CCEL Q2 2026 Earnings: Positive Earnings Surprise as EPS Turns ProfitableWeak Earnings Momentum - vinanet.vn
These 4 Companies Dominate the Cord Blood Processing Industry in 2026-27 - BioInformant
Cryo-Cell International Inc (CCEL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cryo-Cell International Inc (CCEL) Balance Sheet - tradingkey.com
Cryo-Cell International Inc (CCEL) Valuation: PE, PB & Fair Value Analysis - TradingKey
CCEL|Cryo-Cell International Inc|Price:3.460|Chg%:+0.040 - tradingkey.com
Cryo Cell International Inc Stock (CCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):